期刊文献+

环氧合酶-2和survivin在B细胞非霍奇金淋巴瘤中的表达及意义

Expression and clinical significance of COX-2 and survivin in B cell non-Hodgkin′s lymphoma
下载PDF
导出
摘要 目的:探讨环氧合酶-2(COX-2)和survivin在B细胞非霍奇金淋巴瘤(B-NHL)中的表达及临床意义。方法:采用免疫组化SP法检测43例B-NHL(B-NHL组)和10例良性淋巴结病变组织(对照组)中COX-2和survivin的表达。结果:COX-2和survivin在B-NHL组中的阳性表达率分别为55.8%(24/43)和69.8%(30/43),与对照组相比差异具有显著性(分别P<0.05和0.01)。Ⅲ/Ⅳ期B-NHL患者COX-2蛋白的表达要高于Ⅰ/Ⅱ期患者(P<0.05)。Survivin的表达与B-NHL的组织病理学等级和国际预后指数具有相关性(P<0.05)。Spearman相关分析表明COX-2的表达与survivin的表达呈正相关(r=1.000,P=0.030)。结论:COX-2和survivin在B-NHL中表达上调,两者之间的阳性表达密切相关,表明COX-2和survivin在B-NHL的发生和发展中具有协同作用。 Objective To investigate the expression and clinical significance of COX-2 and survivin in B cell non-Hodgkin's lymphoma(B-NHL). Method The expression of COX-2 and survivin in 43 cases of B-NHL and 10 cases of benign lymph node lesions were detected by immunohistochemical streptavidin-biotin peroxidase method. Results The expression rate of COX-2 and survivin in B-NHL was 55.8% (24/43) and 69.8%(30/43), respectively, being significantly higher than that in control group(P 〈 0.05 or P 〈 0.01 ). The expression of COX-2 in B-NHL patients with stage Ⅲ/Ⅳ was higher than that in patients with stage Ⅰ / Ⅱ(P 〈 0.05). The expression of survivin was related with histopathologic grade and IPI of B-NHL (P 〈 0.05). Spearman's correlation analysis showed COX-2 expression was positively correlated with survivin expression (r=1.000, P=0.030). Conclusion The specific up-regulation of COX-2 and survivin in B-NHL and the positive correlation between expression of COX-2 and survivin shows that they have an synergistic effect in the development and progression of B-NHL.
出处 《实用医学杂志》 CAS 2007年第21期3344-3347,共4页 The Journal of Practical Medicine
关键词 非霍奇金淋巴瘤 免疫组织化学 环氧合酶-2 SURVIVIN 表达 临床意义 Lymphoma, non-Hodgkin lmmunohistochemistry Cyclooxygenase-2 Survivin
  • 相关文献

参考文献10

二级参考文献91

  • 1Nasu S, Yagihashi A, Izawa A, et al. Survivin mRNA expression in patients with breast cancer. Anticancer Res,2002,22(3):1839-1843.
  • 2Yu J, Leung WK, Ebert MP, et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer,2002, 87(1): 91-97.
  • 3Denkert C, Winzer KJ, Muller BM, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer,2003, 97(12): 2978-2987.
  • 4Charalambous MP, Maihofner C, Bhambra U, et al. Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. Br J Cancer,2003, 88(10):1598-1604.
  • 5Chakravarti A, Zhai GG, Zhang M, et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene,2004,23(45):7494-7506.
  • 6Dickens DS, Kozielski R, Khan J, et al. Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol,2002, 5(4):356-364.
  • 7Krysan K, Dalwadi H, Sharma S, et al. Cyclooxygenase-2 dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res,2004, 64(18):6359-6362.
  • 8Ristimaki A , Nieminen O , Saukkonen K , et al.Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am J Pathol,2001,158(12) :849-853.
  • 9Howe LR, Dannenberg AJ. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer . Semin Oncol , 2002,29( 3) : 111-119.
  • 10Hao X , Bishop AE , Wallace M , et al . Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol, 2000,187( 5) :295-301.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部